AI to predict kidney disease in type 2 diabetes
Aim of the Study
This study, being conducted by Deakin University aims to understand how people living with type 2 diabetes feel about the use of artificial intelligence (AI) in predicting and screening for diabetes-related kidney disease (DRKD).
DRKD is a serious complication and a leading cause of kidney failure. While AI has the potential to improve early detection or prediction, little is known about how patients perceive and trust its use, or how they prefer AI-generated health risk information to be communicated.
Who can participate in this study?
Participants must be adults aged 18 years or older and meet the following criteria:
- Have a diagnosis of type 2 diabetes
- Be able to read and understand English
- Have access to the internet and be able to complete an online survey
What Participants Can Expect
Participants will complete an anonymous online survey, taking approximately 20 – 30 minutes. The survey includes a combination of rating-scale and open-ended questions. Participants may skip any questions or withdraw at any time.
How will this survey help people living with diabetes?
Findings will help researchers and healthcare providers better understand patient perspectives and guide how AI-based risk information is communicated in diabetes care.
To find out more about this study, click here.
To take part in the survey, follow this link: https://researchsurveys.deakin.edu.au/jfe/form/SV_aXyISILeUUFhrBs